VGK: Short Interest Creeps Higher but Hedging Demand Stays Firm

VGK is in a holding pattern this week, with short interest and options hedging both holding near the elevated levels reported in last week's note, neither retreating nor accelerating.

Short interest has edged marginally higher since the October 28 note flagged the reversal. Shares short rose another 3.3% on the day to 6.5 million, now representing 2.34% of the free float, and are up roughly 15% over the past month. That is a continuation rather than a fresh move: the story remains one of a rebuild from mid-October lows near 5.0 million, with the September high of around 6.0 million now clearly in the rear-view mirror. The borrow market itself is relaxed. Cost to borrow is 0.76%, near its lowest level of the past six weeks after falling sharply through October. Availability runs at 181%, meaning roughly 15 million shares remain available to lend against the 6.5 million currently short. No squeeze pressure is building in the lending pool.

Options positioning has also held firm without breaking to a new extreme. The put/call ratio is 0.60, one standard deviation above its 20-day average of 0.50. That is elevated relative to the September baseline, when the PCR was running closer to 0.37 to 0.40, but it has not pushed materially beyond where it was when last week's note was written. The 52-week PCR range spans 0.32 to 3.03, so the current reading is well off any stress level. Options traders are running more defensive than usual for VGK, but the hedging demand looks measured rather than alarmed.

The fund itself closed at $87.54, down 0.59% on the day but up 0.57% on the week and 1.3% over the past month. For a broad European equity ETF, those are unremarkable moves. JPMorgan Chase remains the largest disclosed holder at 10.3% of shares, though it trimmed by roughly 1.2 million shares as of the June 30 filing. Morgan Stanley reduced its position by around 245,000 shares over the same period. On the other side, Jane Street added 1.6 million shares to bring its position to 3.0 million, a notable build for a market maker with few long-term incentives to hold passively.

The ORTEX short score sits at 46.6, up from 42.6 two weeks ago, tracking the direction of short interest without reaching any extreme. It has been range-bound between 44 and 47 for most of the past fortnight.

What to watch next is whether the short interest rebuild continues through its current pace or stalls at the 6.5 million level, and whether the PCR drifts back toward its September range as the European macro backdrop stabilises, or firms further if eurozone data disappoints.